ePharmacy’s Next Battle Is Bigger Than Medicine Delivery

Emphasis on healthcare accessibility and efforts to integrate digital healthcare platforms are laying a strong foundation for epharmacy business growth. Kings Research estimated the ePharmacy market to expand at an impressive 17.12% CAGR from 2026 to 2033. While the growth outlook seems bright, the market is moving beyond the business model of just offering medicines through online platforms. The structural transformation of epharmacies is where the bigger story lies.

What is an ePharmacy?

ePharmacy is an online website, app, or digital platform that allows users to order prescription or OTC medications and have them delivered right to their doorstep. High demand for convenience and growing digitization around the world are primarily boosting the popularity of epharmacies. Most epharmacies operate on inventory or marketplace models. Identifying which factors drive recurring revenue and which drive one-time purchases remains essential in maximizing the profitability of epharmacies.

Chronic Care Could Become the Economic Engine of ePharmacy

The need for medication regimens that go on for years on end or even lifetimes for chronic diseases creates sustained and recurring revenue for epharmacies. Better medication adherence through synchronization of digital health platforms is also a key factor that could push patients suffering from chronic diseases to opt for epharmacies.

The growing geriatric population is a factor that could help sustain the chronic care argument. While this shows promise, assured growth is not something these factors alone promote. With the world population of adults aged 65 and older expected to rise from 10.5% to 19.6% between 2025 and 2060, epharmacies should explore the geriatric aspect. These numbers from the United States Census Bureau can predict a broader trend of more medication sales, as older people are more at risk for chronic diseases such as diabetes, hypertension, depression, and arthritis.

Mobility barriers, transparent pricing, and limited financial relief through discounts are making epharmacies vital in geriatric care. Easy digital payment access can also help improve medication sales via epharmacies among older adults. Reliance on geriatric business alone cannot sustain an epharmacy, but capitalizing on it is where the real value comes in. Mitigating the risk of polypharmacy in the elderly population will also be a crucial factor in determining the success of epharmacies for this population sect.

Can ePharmacies Achieve Sustainable Unit Economics without Relying Heavily on Discounts?

Most epharmacies are launched and promoted on a discount-first approach. This allows them to penetrate the market and compete with established players and conventional retail pharmacies. However, this business model is not sustainable in the long term. Focusing on maximizing convenience, adding value-added services, and offering reliable chronic care management can help epharmacies attain sustainable profits.

High customer acquisition costs, a drop in valuations, and pushback from local chemist associations make discounts a challenge in the long run. Optimizing last-mile delivery and warehousing should be the primary concerns of epharmacies looking to improve their economic feasibility. Creating hybrid B2B and B2C models can also help improve profitability for epharmacies.

ePharmacies focusing on achieving profitability and sustainable unit economics should focus on mitigating these challenges.

• The Loyalty Mirage: Chronic patients have zero brand loyalty when pricing is the sole differentiator, as they will instantly migrate to a rival app offering an extra 2% off.
• Working Capital Choke: Keeping massive central stocks to support long-distance shipping locks up immense capital and exposes the company to massive inventory expiration write-offs if demand patterns fluctuate. This could be the challenge that breaks any epharmacy that has an improper inventory management system.
• Regulatory Ambiguity and Lack of Specific Laws: Laws and regulations surrounding online pharmacies are ambiguous or vary widely across countries and even cities and states in some cases. Navigating the regulatory landscape requires epharmacies to stay on top of every regulatory and legal change.

ePharmacies Now: Holistic Health Ecosystems of Tomorrow

ePharmacies are expected to move beyond medicine sales and emerge as integrated care hubs for vaccination, immunization, and diagnostic services. Businesses can also focus on offering wellness services that allow them to stand out from epharmacies just selling medications. With the massive influx of new players in the ePharmacy sector, differentiation is not just a brand requirement but a crucial business move.

Pharmacy2U, a regulated ePharmacy, announced the launch of a dedicated women’s health hub in May 2026. The new solution brings together menopause-friendly products, education, and support in a single place. Pharmacy2U teamed up with MTick to confirm whether products have been independently assessed as menopause-friendly.

Offering online consultations, health care memberships, and private-label healthcare products is helping epharmacies diversify their revenue streams. Weight management and wellness support are among the most opportune segments where epharmacies can excel. Capitalizing on the growing Ozempic trend, epharmacies can emerge as specialty channels for the delivery and sales of certain weight management medications. Preventive healthcare is another trend that can help epharmacies expand their business outlook in the long run.

TrumpRx: Economic Relief for Patients or Threat for Pharmacies?

The U.S. is one of the most expensive healthcare markets in the world. The burden of high medication costs has weighed down America for a long time. President Donald Trump announced the launch of TrumpRx in February 2026. The platform isn’t directly selling drugs to patients but offers coupons that patients can take to a pharmacy and fill their prescriptions at cash-pay prices. With products at up to a 98% discount, the drug pricing landscape of America is expected to take a major hit.

Pharmacy sales volume is anticipated to decline if consumers have direct access to drugs at a lower price directly from manufacturers through a federal portal. The question this raises is not just about medication sales but about how necessary pharmacies are in the healthcare supply chain. The battle for pharmacies, whether online or offline, will not be just about price but about relevance. Emphasizing the unique proposition of medication management, clinical consultation, and human connection will be essential for pharmacies to stay relevant.

The ripple effects of this platform launch are expected to echo throughout the healthcare supply chain, well beyond online and offline pharmacies. However, the transformation and impact aren’t going to happen overnight. The success of the platform will be completely dependent on patients being willing to purchase medications not included in their insurance plans. Manufacturers and the platform itself could face legal and logistical hurdles that could make or break the pharmacy businesses. Watching closely how this platform evolves and performs should be a priority for all healthcare payers as well as providers in the long run. Connect with analysts at Kings Research to find what other factors are shaping the epharmacy industry development.

How Far Can ePharmacies Accelerate Delivery without Compromising Quality and Compliance?

Quick commerce has completely transformed expectations around online delivery platforms. ePharmacies are also competing on how fast they can go from order to delivery. While this may be a good thing on the consumer end, the order-to-delivery timeline is what separates a safe epharmacy business model from a potentially dangerous one.

In August 2025, Zepto, a quick commerce platform from India, entered the epharmacy business with the launch of Zepto Pharmacy. The service promises delivery of medicines in select metropolitan cities across the country in 10 minutes. The co-founder and CEO, Aadir Palicha, also stated that the launch follows a 12-month pilot phase, focused on refining operations.

Safe delivery timelines for epharmacies usually range between 2 and 48 hours. Pharmacies promising to deliver medications in 10 minutes and a half hour can create issues in compliance. The same-day delivery model is also considered safe, as it gives time for pharmacists and prescription reviewers to verify the orders and prescriptions submitted therewith. Instant and quick commerce delivery models are something that elevates the risk of an epharmacy running into non-compliance. Trends point toward a future where epharmacies are quick to deliver, but taking this insight with a pinch of salt is necessary.

Compliance is non-negotiable, and speed in delivery comes at the cost of compliance. Choosing either could result in issues, but finding the right balance is where epharmacy businesses can strive.

Why Prescription Segment Remains the Top Money Maker for ePharmacies?

The growing incidence of chronic diseases and high use of prescribed medicine for the treatment of the same allows epharmacies to earn the most from the prescription segment. As per Kings Research, prescription drugs accounted for around 77.32% of the global epharmacy market share in 2025. Rising emphasis on improving accessibility to pharmaceuticals and growing patient demand for convenience are also cementing the dominance of this segment. Emphasis on ensuring regulated medicine access through physician-managed pathways also helped the prescription segment amass a USD 95.19 billion valuation in 2025.

The dominance of prescriptions doesn’t mean the over-the-counter (OTC) segment lacks potential. The trend of self-medication is expected to help boost the demand for OTC products ordered from online pharmacies. Increased digital healthcare access and rising healthcare costs are also expected to contribute to the hike in demand for OTC medicines from epharmacies.

Does the Rise of ePharmacies Mean Decline of Retail Pharmacies?

The short answer is no, but the rise of online pharmacies is forcing a structural change in the retail pharmacy business. The highly fragmented retail pharmacy space needs to focus on technology adoption and consolidate its lead before ePharmacies enter with offline stores, which is happening.

Reliance Retail has entered the pharmacy store business through its Netmeds subsidiary. India has a massive retail pharmacy business space that is largely unorganized; such moves by epharmacies can put traditional brick-and-mortar pharmacy businesses in jeopardy for their brand value.

The retail pharmacy sector could witness the entry of multiple epharmacy brands in the future. Having an online as well as an offline retail channel could give epharmacies a much-needed advantage over conventional pharmacy businesses. Adoption of pharmacy automation solutions, better discounts, and better patient-pharmacist relationships could help retail pharmacies stay competitive in the long run.

What Determines the Success of Next Wave of ePharmacies?

Offering an ecosystem of healthcare services and not just fast-tracking delivery will determine the success of future epharmacy companies. Consumer behaviour has surely changed with the growing digitization of healthcare.

According to research, around 80% of consumers reported changes in their offline purchasing habits after using epharmacy platforms. This is a testament to how epharmacies are reshaping traditional pharmacy approaches instead of replacing them completely. Compliance and regulatory mandates are expected to be major challenges for almost all epharmacies looking to make an impact in the long run. 

Navigating these challenges and sustaining unit economics to maintain profitability are things every epharmacy needs. Find out more about other challenges and how the epharmacy business landscape is changing with Kings Research.

FAQs

How do ePharmacies make money?

ePharmacies generate revenue primarily through medicine sales, but many are expanding their business models through diagnostics, teleconsultations, subscriptions, wellness products, private-label products, and other healthcare services. This diversification allows platforms to generate revenue from multiple stages of the healthcare journey rather than relying solely on individual medicine orders.

Why are ePharmacies expanding beyond medicine delivery?

ePharmacies are expanding beyond medicine delivery to diversify revenue, increase customer engagement, and capture more stages of the healthcare journey. Services such as diagnostics, teleconsultation, chronic-care management, subscriptions, and wellness can create additional customer interactions and recurring revenue opportunities.

What is changing the economics of the ePharmacy market?

The economics of epharmacy are shaped by customer acquisition costs, order frequency, average order value, medicine margins, discounts, inventory management, fulfillment costs, and last-mile delivery expenses. Platforms are therefore expanding into recurring and higher-value services such as chronic-care programs, diagnostics, subscriptions, and private-label products to diversify revenue and improve customer retention.

What is TrumpRx, and how does it affect the ePharmacy market?

TrumpRx.gov is a U.S. government website launched in February 2026 that provides consumers with access to discounts on selected prescription medicines, including manufacturer-linked pricing and coupons. At launch, the platform featured medicines from five manufacturers and was designed to give cash-paying patients access to lower prices on selected drugs.

What is the future of the ePharmacy market?

The ePharmacy market is likely to evolve toward integrated digital healthcare models in which medicine delivery is combined with diagnostics, telehealth, chronic-care management, subscriptions, wellness, and other services. The longer-term opportunity will depend on whether platforms can combine convenient digital access with sustainable economics, regulatory compliance, and recurring patient relationships.